Erratum to: Lesinurad, a novel, oral compound for gout, acts to decrease serum uric acid through inhibition of urate transporters in the kidney
更正:雷西那德是一种新型口服痛风化合物,其作用机制是通过抑制肾脏中的尿酸转运蛋白来降低血清尿酸水平。
期刊:Arthritis Research & Therapy
影响因子:4.6
doi:10.1186/s13075-016-1150-7
Miner, Jeffrey N; Tan, Philip K; Hyndman, David; Liu, Sha; Iverson, Cory; Nanavati, Payal; Hagerty, David T; Manhard, Kimberly; Shen, Zancong; Girardet, Jean-Luc; Yeh, Li-Tain; Terkeltaub, Robert; Quart, Barry